Our CEO’s perspective on microorganisms continues. While we wait for the next one, read the article below: For those without a scientific background, the word “molecule” […]
Our CEO’s perspective about microorganisms. Without microorganisms, we would not have many of the green processes that provide us with useful commodities and important food supplements […]
Today we took another key step toward the goal. There it is: the machine that will speed up materially the molecules’ cataloging, starting from our microorganisms. We are very proud and happy about it […]
An interesting overview on a truly hot Topic from our CFO. Biotech is undeniably an attractive market. Nevertheless it is crucial to pick the right opportunity. […]
This article is about the differences between marine and terrestrial microbial natural products. Findings say that no major differences have been found out throughout the help […]
Investments addressed to Biotech Innovative Companies keep on growing. Have a look on what happened to DNA Nexus after a 100$ million raise co-led by @Perceptive […]
MARBLES will use a novel and systematic approach to access and exploit marine microbial biodiversity for sustainable bioprospecting to discover microbial consortia and bioactive molecules for […]
The growing importance of starting the Drug Discovery process from natural-product-derived and synthetic small molecules is underlined by this article from Nature Reviews Chemistry – https://www.nature.com/articles/s41570-021-00313-1 […]